2018
DOI: 10.1016/j.mayocp.2018.09.008
|View full text |Cite
|
Sign up to set email alerts
|

Seek and You Shall Find: Is Subclinical Amyloid More Common Than Expected?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2019
2019
2021
2021

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 9 publications
0
2
0
Order By: Relevance
“…The A551P variant was identified in a patient presenting, in addition to AGel, another rare amyloidosis caused by a mutant of the transthyretin protein (ATTR-V122I) [30] , [37] . The patient did not have any clinical signs typical of AGel and overall A551P deposition appeared to be responsible for a mild phenotype.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The A551P variant was identified in a patient presenting, in addition to AGel, another rare amyloidosis caused by a mutant of the transthyretin protein (ATTR-V122I) [30] , [37] . The patient did not have any clinical signs typical of AGel and overall A551P deposition appeared to be responsible for a mild phenotype.…”
Section: Discussionmentioning
confidence: 99%
“…Possible furin-alternative processes have been suggested for a sporadic form of AGel associated with the deposition of wild-type (WT) GSN, which is resistant to furin proteolysis [36] . Ex vivo mass spectrometry of amyloid deposits from AGel patients carrying the G167R [20] , A551P [30] , [37] and unidentified mutations [19] revealed fragments not corresponding to the 5 and 8 kDa product of furin and MMP proteolysis. It is not yet known whether these peptides originate from alternative proteolytic patterns or from the fragmentation of full-length GSN during the analysis.…”
Section: Introductionmentioning
confidence: 98%